Hall P A, d'Ardenne A J, Stansfeld A G
Department of Histopathology, St Bartholomew's Hospital, London, UK.
Histopathology. 1988 Aug;13(2):149-60. doi: 10.1111/j.1365-2559.1988.tb02020.x.
Reagents that recognize antigens on lymphoid cells in fixed and wax-embedded sections have been applied to a series of cases of non-Hodgkin's lymphomas. The panel consisted of MB1, 4KB5 (CD45r), LN1, L26 and MB2 which recognize antigens expressed predominantly on B-lymphocytes; UCHL1 and MT1 which recognize antigens expressed on T-lymphocytes and myeloid cells; antibodies recognizing the non-lineage antigens LeuM1 (CD15), BerH2 (CD30), anti-EMA; anti-lysozyme and MAC 387 which detect antigens present on some macrophages; and finally TAL1B5 (class II MHC), CAM 5.2 (low molecular weight cytokeratin) and PD7/26 + 2B11(CD45). Two hundred and four cases of non-Hodgkin's lymphoma have been studied, of which 158 had been fully characterized on frozen sections. The series was biased towards high-grade (n = 108) and T-cell (n = 44) tumours and these were largely prospectively accrued. It was found that discrimination between B-cell and T-cell lymphomas can be reliably achieved using these reagents and that a small panel (CD45, L26, MB2, MT1, UCHL1) is adequate for this purpose. Using the full range of reagents it is not possible to subdivide cases into groups that correspond with morphological subtypes of lymphoma. Although paraffin section immunohistochemistry is of value, the diagnosis of lymphoproliferative disorders must still be based upon the assessment of well fixed, carefully prepared tissue sections using conventional tinctorial methods.
能够识别固定及石蜡包埋切片中淋巴细胞抗原的试剂已应用于一系列非霍奇金淋巴瘤病例。该试剂组包括识别主要在B淋巴细胞上表达的抗原的MB1、4KB5(CD45r)、LN1、L26和MB2;识别在T淋巴细胞和髓细胞上表达的抗原的UCHL1和MT1;识别非谱系抗原LeuM1(CD15)、BerH2(CD30)、抗上皮膜抗原(anti-EMA);抗溶菌酶以及检测某些巨噬细胞上存在的抗原的MAC 387;最后是TAL1B5(II类主要组织相容性复合体)、CAM 5.2(低分子量细胞角蛋白)和PD7/26 + 2B11(CD45)。已对204例非霍奇金淋巴瘤进行了研究,其中158例在冰冻切片上已得到充分表征。该系列病例偏向于高级别(n = 108)和T细胞(n = 44)肿瘤,并且这些病例大多是前瞻性收集的。结果发现,使用这些试剂能够可靠地区分B细胞和T细胞淋巴瘤,并且一小套试剂(CD45、L26、MB2、MT1、UCHL1)足以实现这一目的。使用全套试剂无法将病例细分为与淋巴瘤形态学亚型相对应的组。尽管石蜡切片免疫组织化学有价值,但淋巴增殖性疾病的诊断仍必须基于使用传统染色方法对固定良好、制备仔细的组织切片进行评估。